21-Gene recurrence score assay as a predictor of adjuvant chemotherapy administration for early-stage breast cancer: An analysis of use, therapeutic implications, and disparity profile

Jagar Jasem, Arya Amini, Rachel Rabinovitch, Virginia F. Borges, Anthony Elias, Christine M. Fisher, Peter Kabos

Research output: Contribution to journal › Article › peer-review

37 Scopus citations

Fingerprint

Dive into the research topics of '21-Gene recurrence score assay as a predictor of adjuvant chemotherapy administration for early-stage breast cancer: An analysis of use, therapeutic implications, and disparity profile'. Together they form a unique fingerprint.

Medicine & Life Sciences